Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas T Funderburg

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Ebiomedicine|July 19, 2016
Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV InfectionNicholas T Funderburg
Current Opinion in HIV and AIDS|November 27, 2013
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsNicholas T Funderburg
Current HIV/AIDS Reports|April 18, 2019
Lipidome Abnormalities and Cardiovascular Disease Risk in HIV InfectionEmily Bowman, Nicholas T Funderburg
Current HIV/AIDS Reports|April 24, 2017
Inflammation, Immune Activation, and Antiretroviral Therapy in HIVCorrilynn O Hileman, Nicholas T Funderburg
Current HIV/AIDS Reports|June 2, 2016
Lipid Abnormalities and Inflammation in HIV InflectionNicholas T Funderburg, Nehal N Mehta
Thrombosis Research|April 25, 2014
Coagulation and morbidity in treated HIV infectionNicholas T Funderburg, Michael M Lederman
Journal of Leukocyte Biology|July 20, 2012
Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patientsNicholas T Funderburg, Scott F Sieg
Current HIV/AIDS Reports|June 15, 2020
Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIVAaren Kettelhut, Emily Bowman, Nicholas T Funderburg
Trends in Microbiology|October 16, 2012
Microbial translocation, immune activation, and HIV diseaseNichole R Klatt, Nicholas T Funderburg, Jason M Brenchley
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Reply to Chen et alNicholas T Funderburg, Carey L Shive, Michael M Lederman
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Ebiomedicine|July 19, 2016
Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV InfectionNicholas T Funderburg
Current Opinion in HIV and AIDS|November 27, 2013
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsNicholas T Funderburg
Current HIV/AIDS Reports|April 18, 2019
Lipidome Abnormalities and Cardiovascular Disease Risk in HIV InfectionEmily Bowman, Nicholas T Funderburg
Current HIV/AIDS Reports|April 24, 2017
Inflammation, Immune Activation, and Antiretroviral Therapy in HIVCorrilynn O Hileman, Nicholas T Funderburg
Current HIV/AIDS Reports|June 2, 2016
Lipid Abnormalities and Inflammation in HIV InflectionNicholas T Funderburg, Nehal N Mehta
Thrombosis Research|April 25, 2014
Coagulation and morbidity in treated HIV infectionNicholas T Funderburg, Michael M Lederman
Journal of Leukocyte Biology|July 20, 2012
Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patientsNicholas T Funderburg, Scott F Sieg
Current HIV/AIDS Reports|June 15, 2020
Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIVAaren Kettelhut, Emily Bowman, Nicholas T Funderburg
Trends in Microbiology|October 16, 2012
Microbial translocation, immune activation, and HIV diseaseNichole R Klatt, Nicholas T Funderburg, Jason M Brenchley
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Reply to Chen et alNicholas T Funderburg, Carey L Shive, Michael M Lederman
Pageof 10